19.06.2013 - The University of Southern Denmark will host a new centre dedicated to genomics, proteomics and lipidomics analysis and biological network analysis.
The research infrastructure, which gained an €8m funding form the Villum Foundation, will be located at the Center for Bioanalytical Sciences of the university. "The grant is a huge boost to our interdisciplinary research programs in the biological sciences, " said Ole Jensen, who will head the new centre. "It provides us with new equipment to investigate complex biological systems, from individual biomolecules all the way to genomes, proteomes and metabolomes and systems-wide studies."
The centre will incorporate instrumentation for genomics, proteomics and lipidomics studies, and equipment and computers for detailed analysis of biomolecular structures, interactions and networks. "Integration of experimental and computational approaches is essential in modern biological research and this infrastructure grant provides us with a very strong platform for data storage, data integration and computational modelling of biomolecules and cellular networks, to the benefit of SDU researchers and their collaborators", said Jensen.
The University of Southern Denmark is already an established excellence centre for expression proteomics, pushed by funding of Denmark's government in the past.
29.07.2015 Newly founded Mereo BioPharma has acquired three mid-stage clinical assets from Novartis. In turn, the Swiss pharma concern will hold a stake in the UK company. Other investors are also on board.
24.07.2015 Biotech companies across Europe continue to raise cash on the public markets, generating €3bn in total financing proceedings in the first half of 2015. Compared to 2014, this is almost twice as much.
23.07.2015 US money keeps flowing into Europe's biotechs. As the race for the peanut allergy market heats up, NASDAQ listed French biotech DBV has announced the successful closing of US$281m (€256m) share offering for its allergy products.
16.07.2015 Sanofi has announced plans to restructure its business in five standalone global business units starting in January 2016. The goal is to promote growth and help the company launch a catalogue of new drugs over the next five years.
15.07.2015 GlaxoSmithKline (GSK) has become the first drugmaker to join the Francis Crick Institute. It is a consortium made up of six scientific and academic institutes to conduct research and drug development in the UK. The new institute is set to become a world-leading centre of biomedical research and innovation.
10.07.2015 Karolinska Development has slashed the reported value of its portfolio by almost half by revising its valuation model for early stage companies and divesting its shares in pain med maker Pharmanest.
The BioShake series contains high-speed mixer and thermal mixer for small and very small volumes in microplates and reaction tubes and allows for the first time high precise and efficient mixing in the microliter scale for a wide range of applications. more